Understanding the role of lipopolysaccharide in bacteria
Illuminating the essential role of the outer membrane component and drug target, lipopolysaccharide
This study is looking at how a part of certain bacteria called lipopolysaccharide (LPS) helps them grow and divide, which could help us understand why some bacteria are becoming resistant to antibiotics, especially for those interested in fighting infections caused by these tough germs.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project ID | NIH-10861024 on NIH RePORTER |
What this research studies
This research investigates the function of lipopolysaccharide (LPS), a crucial component of the outer membrane in gram-negative bacteria like Acinetobacter baumannii. By using genetically modified E. coli strains, the study aims to explore how LPS affects cell growth, morphology, and division. The researchers will manipulate LPS synthesis and charge to determine its essential roles in bacterial biology, which could lead to new insights into antibiotic resistance mechanisms. This work is particularly relevant given the rise of antibiotic-resistant strains that lack LPS.
Who could benefit from this research
Good fit: Patients with infections caused by Acinetobacter baumannii or other gram-negative bacteria may benefit from this research.
Not a fit: Patients with infections caused by gram-positive bacteria or those not affected by antibiotic resistance may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for combating antibiotic-resistant bacterial infections.
How similar studies have performed: Previous research has shown that understanding bacterial cell envelope components can lead to breakthroughs in treating infections, indicating potential success for this approach.
Where this research is happening
Saint Louis, United States
- Washington University — Saint Louis, United States (Active)
Researchers
- Principal investigator: Valdez, Ryan Adam — Washington University
- Study coordinator: Valdez, Ryan Adam
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.